{"id":321088,"date":"2026-10-21T16:01:05","date_gmt":"2026-10-21T10:31:05","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=321088"},"modified":"2026-10-21T16:01:05","modified_gmt":"2026-10-21T10:31:05","slug":"global-generics-branded-generics-and-contract-formulations-stocks-roadmap-ascent-list","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/global-generics-branded-generics-and-contract-formulations-stocks-roadmap-ascent-list\/","title":{"rendered":"3 Global Generics, Branded Generics and Contract Formulations Stocks With a Strong Future Roadmap: Aurobindo Pharma, Emcure Pharmaceuticals and Innova Captab"},"content":{"rendered":"

Aurobindo Pharma, Emcure Pharmaceuticals and Innova Captab: ROE of 9.2% to 18.7% and FY22 to FY26 revenue CAGR of 9.5% to 19.5%. Prices as of 20 Oct 2026.<\/em><\/p>\n

\n

Quick Answer<\/strong><\/p>\n

The three generic and branded pharma stocks to watch are Aurobindo Pharma, Emcure Pharmaceuticals and Innova Captab. Their return on equity ranges from 9.2% to 18.7%, and their revenue compound annual growth from FY22 to FY26 ranges from 9.5% to 19.5%. Emcure Pharmaceuticals has the highest return on equity at 18.7%, while Innova Captab has the fastest revenue growth at 19.5% a year. Prices are based on the 20 October 2026 close, and this article is educational, not investment advice.<\/p>\n<\/div>\n

Generic and branded pharma stocks follow the companies that make everyday medicines for patients in India and abroad. Aurobindo Pharma, Emcure Pharmaceuticals and Innova Captab show three models: a global generics major, a branded generics company with a strong domestic franchise and a contract manufacturer with its own formulations.<\/p>\n

This list covers three generic and branded pharma stocks with complete current figures: Aurobindo Pharma, Emcure Pharmaceuticals and Innova Captab. Every figure comes from the latest reported financials and the 20 October 2026 market close. Companies without complete current figures were left out.<\/p>\n

Click Here – Get Free Investment Predictions<\/a><\/strong><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n